# China NMPA Drug Inspection - Guangdong Wanfang Pharmaceutical Co., Ltd. - Lily Gold Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangdong-wanfang-pharmaceutical-co-ltd/b2518094-2f14-44c8-b028-43a1f9a19c42/
Source feed: China

> China NMPA drug inspection for Guangdong Wanfang Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Lily Gold Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangdong Wanfang Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Lily Gold Tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangdong-wanfang-pharmaceutical-co-ltd/9f36bc81-0e77-490d-86de-8e15bae9360c/